Welireg 40 mg, Filmtabletten

7680685310026 CH-68531 Filmtabletten
Welireg 40 mg, Filmtabletten
Welireg 40 mg, Filmtabletten
Welireg 40 mg, Filmtabletten
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/11/2025
Patient information leaflet
Français
04/11/2025
Patient information leaflet
Italien
04/11/2025
Summary of Product Characteristics
Allemand
04/11/2025
Summary of Product Characteristics
Français
04/11/2025
Summary of Product Characteristics
Italien
04/11/2025

Detailed composition

Substance Quantity Type Category
belzutifanum
40.0 MG Substance Wirkstoff (Principe actif)
hypromellosi acetas succinas
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
mannitolum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 3350
- Substance HNIDK
talcum
- Substance HNIDK
E 132
- Substance FIMDK
natrium
1.356 MG Substance HBESI

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
68531
Drug name
Welireg, Filmtabletten
Galenic form
FILM
ATC Code
L01XX74
Authorization status
Z
Dispensing category
A
First authorization
21/03/2024
Authorization expiration date
30/06/2030
IT Number
07.16.4.
Domain
Human medicine
Field of application
Von-Hippel-Lindau (VHL) - Krankheit, Fortgeschrittenes Nierenzellkarzinom (RCC)

Package details

Description (FR)
WELIREG cpr pellic 40 mg 90 pce
Description (DE)
WELIREG Filmtabl 40 mg 90 Stk
Market launch
03/03/2026
Narcotic (BTM)
No

Other package sizes (1)

WELIREG cpr pellic 40 mg 90 pce
90 TABL
GTIN: 7680685310019
View
Buy us a coffee Explore the data